Revna Biosciences has carved a niche for itself in Ghana and West Africa by being the first facility in the region to secure dual ISO accreditations: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking. This milestone is a testament to RevnaBio’s unwavering commitment to championing precision medicine by propelling molecular diagnostics and therapeutic discovery in the region. A Pledge to Quality and Patient Care The Americ

A groundbreaking agreement between MSC Group, MSC Foundation and the charity Mercy Ships International prepares for the construction of a brand-new hospital ship that will deliver free surgery and training annually to thousands of people in Africa. On 8 April, the chairman of MSC Group and MSC Foundation, Capt. Gianluigi Aponte, Diego Aponte, MSC Group President and Member of the MSC Foundation Board, and Mercy Ships Founder Don Stephens finalised an agreement to kickstart this new

Connect America, a nationally recognized innovator of virtual care solutions that enable older adults and those living with chronic conditions to live safely and well at home, today announced the launch of their innovative fall prevention program. Designed to help identify, predict and reduce falls among aging and at-risk populations through a comprehensive, integrated approach, the Connect America Fall Prevention Program combines early risk identification, predictive intelligence,

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays. Recently, tests for Hepatitis B and C viruses — namely Access anti-HCV, Access HBsAg, and Access HBsAg Confirmatory assays — received CE marks. Detection of the viral surface antigen (HBsAg) in serum or plasma i

VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) in Shanghai. Drawing on the Group's core competence in R&D and its wealth of top-quality raw materials, devices, modules, and system R&D resources, VITAL HealthCare has captured the spotlight with its forward-looking product development plan on this inaugural showcase. At the exhibition, VITAL HealthCar

Leading hearing care retailer HearUSA today announced plans to open six new state-of-the-art Hearing Centers of the Future in Texas as part of an accelerating drive to expand statewide access to the latest prescription and over-the-counter (OTC) hearing aids, as well as the information and resources that can help Texans shatter the stigma long associated with hearing loss and begin living healthier, more engaged lives. Throughout March and April, the retailer will ope

Cognito Health Inc. ("Cognito"), launched its all-in-one virtual mental health treatment in Ontario. With one affordable subscription, residents can immediately access virtual cognitive behavioral therapy (CBT), medication and personalized help from a dedicated care team. Cognito began offering virtual mental health treatment in BC and is expanding across Canada to help address Canada's mental health care gap. In Statistics Canada'

Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced a collaboration with PlusVitech, a biotechnology company developing treatments for cancer, to use Nanoform's state-of-the-art nanomedicine technology to repurpose the anti-nausea medicine aprepitant as a treatment for lung cancer. The development program will include nanoforming the current active ingredient into crystalline nanoparticles and formulating a simplified dose regimen with

Collette Health, a leading provider of continuous virtual patient observation solutions, announced today at the 2024 American Organization for Nursing Leadership (AONL) Conference three new major platform enhancements to increase patient safety and allow care from anywhere. The features include: A new all-in-one hardware device designed for every room application that can be mounted on the wall or ceiling providing a smaller footprint and reducing costs.

A pioneering non-invasive neurostimulation technology for chronic insomnia will be showcased on the ABHI UK Pavilion at CMEF 2024, offering a glimpse into the future of healthcare innovation. Developed by Neurovalens, a UK-based company and global leader in non-invasive neurostimulation, Modius Sleep presents a paradigm shift in the treatment of chronic insomnia. Utilising a battery-powered headset, the device delivers a small and safe electrical pulse to the head, behind the ears,